CompletedPHASE1, PHASE2NCT00005793

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

Studying Acute erythroid leukemia

Last synced from ClinicalTrials.gov May 11, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator: Hussain I. Saba, MD, PhD, MD
H. Lee Moffitt Cancer Center and Research Institute
Intervention: Cytarabine(drug)
Enrollment: 41 enrolled
Eligibility: 16-59 years · All sexes
Timeline: 1999 – 2006

Study locations (1)

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Collaborators

National Cancer Institute (NCI) · SmithKline Beecham

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00005793 on ClinicalTrials.gov

Other trials for Acute erythroid leukemia

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT00658814
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)

See all trials for Acute erythroid leukemia →

← Back to all trials